Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AACR presentation points to potential new indication for ABX-IL-8: melanoma

March 30, 2001

PG-TXL proves superior to free paclitaxel against human colon cancer xenografts

March 30, 2001

Phase I/II evaluation of Titan's Pivanex begins in liver cancer

March 30, 2001

New vaccine targets for cancer-causing strains of HPV identified

March 30, 2001

NeoPharm files IND for liposomal mitoxantrone

March 30, 2001

Potential new ribonucleotide reductase inhibitors may be more effective than hydroxyurea

March 29, 2001

Bayer presents newest angiogenesis inhibitor series

March 29, 2001

Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer

March 29, 2001

Peptidomimetic and small-molecule uPA inhibitors hold promise as cancer therapeutics

March 29, 2001

Antitumor and antiangiogenic effects demonstrated for new VEGF-binding molecule

March 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...